The ACT EU initiative aims to support the successful and timely implementation of theClinical Trials Regulation(CTR) and its implementing acts. Under ACT EU, theEuropean medicines regulatory network(EMRN) publishes statistics on the authorisation of clinical trials in the European Union (EU)/European Economic Area (EEA). This information provides an insight into how the CTR is transforming the clinical trial environment in the EU/EEA. The reports are based on data retrieved from theClinical Trials Information System (CTIS). Implementation progress reports Targeted surveys collect feedback from clinical trial sponsors on their experience with the implementation of the CTR and the use of CTIS.
ACT EU - Accelerating Clinical Trials · May 20, 2026
ACT EU: Implementation of the Clinical Trials Regulation
Original title: Implementation of the Clinical Trials Regulation
EU regulatory network publishes statistics and progress reports on Clinical Trials Regulation implementation and CTIS usage across EU/EEA.
Published by ACT EU - Accelerating Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.